Information was received from a patient regarding an implantable neurostimulator.The reason for call was caller stated that for about the past 3 months they have noticed that they have to charge their implant every other day.Caller stated that in the beginning they had to charge every 4 days, and after about 6 months it was every 3 days.Caller added that last night their implant battery was at 90% and now it is at 25%, so they'll have to charge again today.Caller stated they have been putting the recharger on when they go to bed because they can sit for 1.5 hours trying to charge the implant which seems longer than it used to be.Caller confirmed the implant does charge up to 100% every time.Caller mentioned that they haven't made any adjustments to their programming because they're very happy with their current settings.Caller stated all they do is worry about how quickly they need to recharge because if the stimulation shuts off the pain is unbearable.Caller mentioned that they just talked to their medtronic rep who gave them the patient services phone number and said to call for a potential replacement.The issue was not resolved.Agent reviewed implant battery depletion was related to programming use.The patient was redirected to their healthcare provider to further address the issue.Caller has an appointment with healthcare provider next wednesday.Of note, caller mentioned they got the temporary implant in (b)(6) 2022 and 6 months later they noticed the recharge frequency was at 3 days rather than 4.
|
B3: event date is not known.Please see b5 for approximate date range, if applicable.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|